Prosthesis, Mitral Valve, Percutaneously Delivered
NPU is the FDA product code for Prosthesis, Mitral Valve, Percutaneously Delivered, a class III device type. FDA's definition for this code reads: "These devices are intended to replace a patient's mitral heart valve. They are different from the classified device (heart valves) in that they are placed percutaniously and do not require open chest surgery or a cardiotomy for placement". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- NPU
- Device name
- Prosthesis, Mitral Valve, Percutaneously Delivered
- FDA definition
- These devices are intended to replace a patient's mitral heart valve. They are different from the classified device (heart valves) in that they are placed percutaniously and do not require open chest surgery or a cardiotomy for placement.
- Device class
- Class III
- Review panel
- Unknown
- Submission type
- PMA
- Implant
- Yes
- Life sustaining or supporting
- Yes
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this code- Abbott Medical
- Abbott Medical Costa Rica Limitada (Structural Heart)
- EDWARDS LIFESCIENCES (SINGAPORE) Pte Ltd
- Edwards Lifesciences Ireland Limited
- Edwards Lifesciences LLC
- Midwest Sterilization Corp.
- Primo Medical Group, Inc
- Sterigenics Belgium (Petit Rechain) SRL
- Sterigenics Costa Rica S.r.l.
- Sterigenics U.S., LLC
- STERIS Tomoe Singapore Pte Ltd
- Synergy Health Ireland Ltd
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
